drug excipient

N,N-Dimethylacetamide (DMAc) is a drug excipient with blood-brain barrier permeability and anti-inflammatory activity, acting through inhibition of the NF-κB signaling pathway. N,N-Dimethylacetamide can reduce endotoxin-induced inflammatory responses in vivo.

DSPE-Fluorescein is a phospholipid known for its excellent biocompatibility and pronounced amphiphilic properties, making it an ideal and prominent excipient or formulation agent in pharmaceuticals to achieve enhanced therapeutic outcomes. [DSPE-Fluorescein] is also applicable in research on drug delivery.

DSPE-Fluor 488 is a phospholipid known for its excellent biocompatibility and distinctive amphiphilic properties, making it an ideal form and excipient in pharmaceutical formulations for enhanced therapeutic outcomes. It is utilized in the study of drug delivery.

DOPE-PEG-FITC (MW 2000) is a phospholipid known for its excellent biocompatibility and significant amphiphilic properties, making it a primary and suitable excipient or formulation in drug delivery systems for enhanced therapeutic outcomes. Additionally, DOPE-PEG-FITC (MW 2000) is useful in research focused on drug delivery mechanisms.

DOPE-PEG-Azide (MW 1000) is a phospholipid known for its excellent biocompatibility and significant amphiphilic properties, making it a primary and suitable formulating agent or excipient in drug formulations for enhanced therapeutic outcomes. It is utilized in research focused on drug delivery.

DOPE-PEG-Azide (MW 3400) is a phospholipid known for its excellent biocompatibility and pronounced amphiphilic properties, making it a key and suitable excipient or formulation in drug delivery systems for enhanced therapeutic outcomes. It is utilized in research focused on drug delivery.

DOPE-PEG-Azide (MW 5000) is a phospholipid known for its excellent biocompatibility and notable amphiphilic properties, making it an ideal component as a formulation type or excipient in pharmaceuticals for enhanced therapeutic outcomes. It is utilized in drug delivery research.

DSPE-polysarcosine66 is a phospholipid known for its excellent biocompatibility and significant amphiphilic properties, making it an ideal primary form or excipient in drug formulations for enhanced therapeutic outcomes. It is used in research for drug delivery.

DSPE-Amide-PEG-Rhodamine (MW 2000) is a phospholipid known for its excellent biocompatibility and pronounced amphiphilicity, making it a key and suitable form or excipient in pharmaceutical formulations to achieve enhanced therapeutic outcomes. DSPE-Amide-PEG-Rhodamine (MW 2000) can be employed in drug delivery research.

DOPE-PEG-FITC (MW 5000) is a phospholipid known for its excellent biocompatibility and distinct amphiphilic properties, making it an ideal and primary excipient or formulation in pharmaceuticals to enhance therapeutic outcomes. Additionally, DOPE-PEG-FITC (MW 5000) is utilized in research focused on drug delivery.

DOPE-PEG-Rhodamine B (MW 5000) is a phospholipid known for its excellent biocompatibility and pronounced amphiphilic properties, making it an ideal and primary excipient in pharmaceutical formulations for enhanced therapeutic outcomes. It is applicable in the research of drug delivery systems.

DOPE-PEG-Cy5.5 (MW 2000) is a phospholipid known for its excellent biocompatibility and pronounced amphiphilic properties, making it a key and suitable excipient or formulation in pharmaceuticals to enhance therapeutic outcomes. DOPE-PEG-Cy5.5 (MW 2000) is applicable in drug delivery research.

DOPE-PEG-Cy5 (MW 5000) is a phospholipid. With excellent biocompatibility and notable amphiphilic properties, phospholipids serve as a primary and suitable formulation or excipient in drug delivery systems, enhancing therapeutic outcomes. DOPE-PEG-Cy5 (MW 5000) is applicable in studies focused on drug delivery.

DOPE-PEG-Cy5.5 (MW 5000) is a phospholipid known for its excellent biocompatibility and significant amphiphilic properties, making it an ideal and primary formulation or excipient in drug delivery to enhance therapeutic efficacy. This compound is applied in research focused on drug delivery methods.

DOPE-PEG-Cy5 (MW 2000) is a phospholipid known for its excellent biocompatibility and significant amphiphilic properties, making it an ideal and essential excipient or formulation type in pharmaceuticals for enhanced therapeutic outcomes. It is applicable in research focusing on drug delivery.

DMPE-PEG-amine (TFA) (MW 2000) is a phospholipid noted for its excellent biocompatibility and significant amphiphilic properties, making it a suitable and key excipient or formulation in drug delivery systems to achieve enhanced therapeutic outcomes. Additionally, DMPE-PEG-amine (TFA) (MW 2000) is applicable in drug delivery research.

DOPE-PEG-COOH (MW 1000) is a phospholipid characterized by excellent biocompatibility and notable amphiphilic properties, making it an ideal and pivotal excipient or dosage form in pharmaceutical formulations for enhanced therapeutic outcomes. It is applicable in studies related to drug delivery.

DOPE-PEG-COOH (MW 3400) is a phospholipid known for excellent biocompatibility and significant amphiphilic properties, making it an ideal and essential excipient or form in drug formulations for enhanced therapeutic efficacy. It is applicable in the research of drug delivery.

DOPE-mPEG (MW 1000) is a phospholipid known for its excellent biocompatibility and significant amphiphilic properties, making it a suitable and primary excipient in pharmaceutical formulations to enhance therapeutic outcomes. It can be utilized in research focused on drug delivery.

DOPE-mPEG (MW 5000) is a phospholipid known for its excellent biocompatibility and pronounced amphiphilic properties, making it an ideal and primary excipient or dosage form in drug formulations to enhance therapeutic outcomes. It is used in the study of drug delivery.

DOPE-PEG-Amine (MW 3400) is a phospholipid known for its excellent biocompatibility and distinct amphipathic properties. These characteristics make it an ideal and primary excipient or dosage form in pharmaceutical formulations, enabling enhanced therapeutic outcomes. Additionally, DOPE-PEG-Amine (MW 3400) can be utilized in drug delivery research.

DOPE-PEG-Amine (MW 5000) is a phospholipid known for its excellent biocompatibility and significant amphiphilic properties, making it a key and suitable excipient in drug formulations to achieve enhanced therapeutic outcomes. It is utilized in research focusing on drug delivery.

DOPE-PEG-Mal (MW 1000) is a phospholipid characterized by excellent biocompatibility and notable amphiphilic properties, making it an ideal primary dosage form or excipient in pharmaceutical formulations for enhanced therapeutic outcomes. It is employed in studies related to drug delivery.

DOPE-PEG-Mal (MW 3400) is a phospholipid known for its excellent biocompatibility and notable amphiphilic properties, making it an ideal and critical component or excipient in drug formulations for enhanced therapeutic outcomes. It can be utilized in drug delivery research.